Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RIPK1 | Q13546 | 2/20 | 0.33 |
| ▸ | ESR1 | P03372 | 1/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.32 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27337058 | 0.83 | SLC6A2 (0.48) | SLC6A2TAAR1 | |
| SCHEMBL29020377 | 0.83 | SLC6A2 (0.30) | SLC6A2TAAR1 | |
| SCHEMBL2698490 | 0.83 | SLC6A2 (0.30) | SLC6A2TAAR1 | |
| SCHEMBL6893898 | 0.81 | — | — | |
| SCHEMBL9620893 | 0.79 | — | — | |
| SCHEMBL6893184 | 0.78 | RIPK1 (0.34) | RIPK1 | |
| SCHEMBL1071248 | 0.78 | — | — | |
| SCHEMBL263226 | 0.77 | — | — | |
| SCHEMBL9586177 | 0.77 | — | — | |
| SCHEMBL8042450 | 0.77 | LMNA (0.40) | RIPK1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 705 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220393118-A1 | TETRADENTATE LIGANDS, GOLD(III) COMPLEXES, PREPARATION METHOD AND USE THEREOF | CHE, CHI MING (CN) | 2022-12-08 | — | — | US | claimed |
| CN-112552256-B | Organic electroluminescent material and organic electroluminescent device using same | 南京高光半导体材料有限公司 | 2022-10-25 | — | — | CN | claimed |
| CN-112442052-B | High-efficiency and long-life blue fluorescent doped material, application thereof and organic electroluminescent device | 南京高光半导体材料有限公司 | 2022-08-26 | — | — | CN | claimed |
| CN-112442053-B | Blue fluorescent doping material with good thermal stability and high efficiency and organic electroluminescent device | 南京高光半导体材料有限公司 | 2022-07-12 | — | — | CN | claimed |
| EP-4017936-A1 | TETRADENTATE LIGANDS, GOLD(III) COMPLEXES, PREPARATION METHOD AND USE THEREOF | Che, Chi Ming (HK) | 2022-06-29 | — | — | EP | claimed |
| CN-112851649-A | Organic electroluminescent compound containing multi-heterocyclic structure, organic electroluminescent device and application | 南京高光半导体材料有限公司 | 2021-05-28 | — | — | CN | claimed |
| CN-112552256-A | Organic electroluminescent material and organic electroluminescent device using same | 南京高光半导体材料有限公司 | 2021-03-26 | — | — | CN | claimed |
| CN-112552255-A | Organic electroluminescent material containing triphenylamine structure and organic electroluminescent device using same | 南京高光半导体材料有限公司 | 2021-03-26 | — | — | CN | claimed |
| CN-112442053-A | Blue fluorescent doping material with good thermal stability and high efficiency and organic electroluminescent device | 南京高光半导体材料有限公司 | 2021-03-05 | — | — | CN | claimed |
| CN-112442052-A | High-efficiency and long-life blue fluorescent doped material, application thereof and organic electroluminescent device | 南京高光半导体材料有限公司 | 2021-03-05 | — | — | CN | claimed |
| CN-105186037-A | Sulphonate stabilizer and non-aqueous electrolyte containing same | UNIV CENTRAL SOUTH | 2015-12-23 | — | — | CN | claimed |
| EP-2786985-A2 | Antagonists of the glucagon receptor | Metabasis Therapeutics, Inc. (US) | 2014-10-08 | — | — | EP | claimed |
| CN-103904363-A | Phosphite stabilizer and nonaqueous electrolyte containing same | DONGGUAN SHANSHAN BATTERY MATERIALS CO LTD | 2014-07-02 | — | — | CN | claimed |
| EP-2484685-A1 | TRANSITION METAL COMPLEX, PREPARATION METHOD FOR SAID TRANSITION METAL COMPLEX, TRIMERIZATION CATALYST, PREPARATION METHOD FOR 1-HEXENE, PREPARATION METHOD FOR ETHYLENE POLYMER, SUBSTITUTED CYCLOPENTADIENE COMPOUND, AND PREPARATION METHOD FOR SAID SUBSTITUTED CYCLOPENTADIENE COMPOUND | Sumitomo Chemical Co., Ltd (JP) | 2012-08-08 | — | — | EP | claimed |
| US-20120184431-A1 | TRANSITION METAL COMPLEX, PREPARATION METHOD FOR SAID TRANSITION METAL COMPLEX, TRIMERIZATION CATALYST, PREPARATION METHOD FOR 1-HEXENE, PREPARATION METHOD FOR ETHYLENE POLYMER, SUBSTITUTED CYCLOPENTADIENE COMPOUND, AND PREPARATION METHOD FOR SAID SUBSTITUTED CYCLOPENTADIENE COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-07-19 | — | — | US | claimed |
| US-20100099875-A1 | NEW ORTHO-FUNCTIONALIZED P-CHIRAL ARYLPHOSPHINES AND DERIVATIVES: THEIR PREPARATION AND USE IN ASYMMETRIC CATALYSIS | PHOSPHOENIX SARL (FR) | 2010-04-22 | — | — | US | claimed |
| EP-2129654-A1 | NOVEL ANTAGONISTS OF THE GLUCAGON RECEPTOR | Metabasis Therapeutics, Inc. (US) | 2009-12-09 | — | — | EP | claimed |
| WO-2008098244-A1 | NOVEL ANTAGONISTS OF THE GLUCAGON RECEPTOR | METABASIS THERAPEUTICS, INC. (US) | 2008-08-14 | — | — | WO | claimed |
| EP-1899358-A2 | NOVEL P-CHIRAL FUNCTIONALISED ARYLPHOSPHINES AND DERIVATIVES, THE PREPARATION AND USE THEREOF FOR ASYMMETRICAL CATALYSIS | Phosphoenix SARL (FR) | 2008-03-19 | — | — | EP | claimed |
| WO-2006136695-A2 | NOVEL P-CHIRAL FUNCTIONALISED ARYLPHOSPHINES AND DERIVATIVES, THE PREPARATION AND USE THEREOF FOR ASYMMETRICAL CATALYSIS | PHOSPHOENIX SARL (FR) | 2006-12-28 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100099875-A1 | NEW ORTHO-FUNCTIONALIZED P-CHIRAL ARYLPHOSPHINES AND DERIVATIVES: THEIR PREPARATION AND USE IN ASYMMETRIC CATALYSIS | PNP, NANP, PHOSPHO1 | RIPK1 3521/4885ESR1 1016/4885SLC6A2 3224/4885 |
| US-20120184431-A1 | TRANSITION METAL COMPLEX, PREPARATION METHOD FOR SAID TRANSITION METAL COMPLEX, TRIMERIZATION CATALYST, PREPARATION METHOD FOR 1-HEXENE, PREPARATION METHOD FOR ETHYLENE POLYMER, SUBSTITUTED CYCLOPENTADIENE COMPOUND, AND PREPARATION METHOD FOR SAID SUBSTITUTED CYCLOPENTADIENE COMPOUND | EMC1, CYC1, AP1M1 | RIPK1 1168/4885ESR1 272/4885SLC6A2 4843/4885 |
| US-20220393118-A1 | TETRADENTATE LIGANDS, GOLD(III) COMPLEXES, PREPARATION METHOD AND USE THEREOF | PDCD2L, TTL, TTLL12 | RIPK1 2962/4885ESR1 3300/4885SLC6A2 1896/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.